Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
4.59 USD | +0.22% |
|
-0.22% | -2.34% |
27/06 | Guggenheim Initiates SOPHiA GENETICS at Buy With $6 Price Target | MT |
24/06 | Sophia Genetics S. A. Launches New Residual Acute Myeloid Application | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.34% | 299M | |
+20.72% | 3,322B | |
+16.25% | 91.17B | |
+14.02% | 84.37B | |
+50.47% | 56.41B | |
-22.01% | 49.69B | |
+35.34% | 47.77B | |
-25.50% | 46.04B | |
+69.41% | 41.02B | |
-4.33% | 27.21B |
- Stock Market
- Equities
- SOPH Stock
- News SOPHiA GENETICS SA
- Morgan Stanley Adjusts Price Target on SOPHiA GENETICS to $11 From $12, Maintains Overweight Rating